Olema Pharmaceuticals, Inc. OLMA Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Olema Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Olema Pharmaceuticals, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Olema Pharmaceuticals, Inc.'s investing cash flow?
- Olema Pharmaceuticals, Inc. (OLMA) reported investing cash flow of $4.53M in Q1 2026.
- How has Olema Pharmaceuticals, Inc.'s investing cash flow changed year-over-year?
- Olema Pharmaceuticals, Inc.'s investing cash flow increased by 110.0% year-over-year, from -$45.08M to $4.53M.
- What is the long-term trend for Olema Pharmaceuticals, Inc.'s investing cash flow?
- Over 2 years (2022 to 2024), Olema Pharmaceuticals, Inc.'s investing cash flow has grown at a 1.1% compound annual growth rate (CAGR), from $91.48M to -$93.53M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.